Fresenius SE & Co. KGaA | Fresenius Ventures
◆ Fund Size
$233.6M
◆ Check Size
◆ Location
Germany
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Invests in founders, technologies, and business models in healthcare innovation adjacent to Fresenius' strategic platforms including (Bio)Pharma, MedTech, and Care Provision. Focus areas include precision nutrition, microbiome research, new modalities, and digital care provision solutions.
◆ About Fresenius SE & Co. KGaA
We are the venture arm of Fresenius, one of the world’s leading global healthcare companies, reaching 450 million people each year across pharmaceuticals, medtech and care delivery. We invest from Series A to growth stage in companies with the ambition to transform healthcare where it matters most: patient care and medical outcomes.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Florian Feick | Vice President Investor Relations; Deputy Head of Investor Relations | VP | |
| Thomas Michael Thestrup | Managing Director and Head of Fresenius Ventures | Founding Managing Director |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Fresenius Ventures invest in?
Fresenius Ventures invests in Biotech, Digital Health, Medtech, Drug Discovery and Diagnostics at the pre-seed, seed, series-a, series-b and growth stages.
Which geographies does Fresenius Ventures focus on?
Fresenius Ventures focuses on Global, and is headquartered in Germany.
What is Fresenius Ventures's typical check size?
Fresenius Ventures typically writes checks of $5M to $15M.